ÃâÒßѧÊÔÌâ
7 (}gs?&w Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
F(
?A7 1. Fas(CD95)/FasL
;QVX'? 2. common chain of cytokine receptor
irg%n 3 . TCR/CD3 complex
<{
Z$!]i1 4. negaive selection of thymocytes
Oy>V/ 5. artificial active immune
;>#YOxPl 6. anti-idiotypic
KW17CJ@ 7. IgSF
)FF3|dZ";K 8. Integrin
,U-aZ 9. chemokine
v61'fQ1Qg! 10. B7/CD28
Het5{Yb. ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
]!v:xjzT 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
h5vvizruy 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
OPYl#3I 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
WH@CH4WM 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
Sqt'}
m^6& !`CD 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
;rD
M%S@ µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
@k"Q e&BQ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
,};UD
W 1. B7/CD28
>= G{.H 2. Th1 subset
$i:wS=
w' 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
9e`.H0 4. antibody affinity maturation
tC
4:cX 5. AP-1
BCrX>Pp}r 6. single chain variable fragment£¨ScFv£©
v2vPfb 7. NK cell receptor
9>@@W#TK~ 8. Zinkernagel-Doherty phenomenon
_8-iO.T+2 9. Ig fold
v,
=[!=8! 10. CD40/CD40L
oNkASAd ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
WcG!6.U> 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
*5kQ6#l 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
e 58 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
?0ezr[`. Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
V*$(T t( 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
,-4SVj8$P 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
n$jOk
|W 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
mKsTA; Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
?iX1;c9 £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
SO~]aFoYt Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
u:6PAVW? 1.Co-stimulators (or co-stimulating molecules)
5|4=uoA< 2.NK-kB
Ql%0%naq1 3.Immunoglobulin superfamily
pPC_ub 4.antigen-presenting cell (APC)
X2Z
E9b 5.death domain
'1$#onx 6.CCR and CXCR
iva?3
.t 7.Lectin (or mitogen)
r`;
"
8.Clusters of differentiation, CD)
~miRnW*x 9.B7 family
FXAP]iqo 10.Cytotoxic T lymphocyte, CTL)
8Wa&&YTB 11.IL-15 and IL-15 receptor (IL-15R)
~J
U
:a@) 12.MHC restriction
Tb2Tb2C 13.Affinity-chromatography
BQs~>}(V 14.Cyctosprin A, CsA
Cb{n4xKW6 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
MzF9 &{N ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
|5ifgSZ 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
-y@5% _- 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
cH5@Jam 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
R^fk
:3 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
@iW^OVpp<8 ÃâÒßѧרҵ£º
vPVA^UPNV 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
@IB+@RmL Ïû»¯ÄÚ¿Æ£º
Xv`c@n
) 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
#4WA2EW ѪҺ²¡Ñ§×¨Òµ£º
\~1>%F'op 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
a ]PS` Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
Kg#5
@; (רҵ»ù´¡: ÃâÒßѧ)
Qx_K) Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
E!a5-SrR 1. ADCC(antibody dependent cell-mediated cytotoxicity)
J!%cHqR 2. »·æß¾úËØ(cyclosporin)
\Ty%E< 3. KIR(killer cell inhibitory receptor)
*-!&5~o/U 4. HLDA(human leucocyte differentiation antigen)
7[V6@K!Al[ 5. Interleukin 18(IL-18)
2Z ?
N 6. ÕûºÏËØ(integrin)
9$9Pv%F:j 7. Fas/FasL
c'9-SY1'~ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
ozs
xqN 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
l_GsQ0 10. Th1/Th2
([-xM%BI6 11. »ùÒòÒßÃç(DNAÒßÃç)
q><E? 12. chemokines and chemokine receptor
Eua\N<!aai 13. ÃâÒßÄÍÊÜ
zuWfR&U|W 14. ¹²´Ì¼¤·Ö×Ó
FyXz(l: 15. ËÀÍö½á¹¹Óò(death domain)
u1?1x ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
Ha~g8R& 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
uZyR{~-C 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
#&Zb8HAj £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
u&iMY3= £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
zh hHA9 £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
4XkSj9D~z £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
{r9fKA 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
_T\~AwVc< Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
rb+&] ÎÊ´ðÌâ(ÿÌâ25·Ö)
JRMe(,u 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
y<|vcg8x 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
bDLPA27 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
Ok-*xd 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£